Recro pharma, inc. (REPH)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13
Assets
Current assets:
Cash and cash equivalents

19,873

19,148

37,944

30,400

45,981

38,514

35,788

48,911

46,284

60,984

11,803

8,728

19,485

64,483

24,752

14,845

14,917

19,779

28,275

15,687

16,590

19,682

23,904

27,832

29,905

12

Short-term investments

-

-

-

1,998

12,034

-

1,243

-

4,989

3,498

29,507

41,517

36,060

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts receivable

14,486

14,389

16,216

17,796

16,218

12,866

11,745

11,671

9,833

9,686

13,126

10,102

12,278

10,411

12,400

11,480

12,182

8,580

9,572

15,024

-

-

-

-

-

-

Contract asset

9,752

8,851

10,643

8,154

5,108

5,201

7,465

6,866

5,508

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other receivables

-

-

-

-

-

-

-

-

-

-

-

-

-

-

60

23

23

-

29

22

80

89

86

0

35

38

Inventory

12,044

15,072

12,921

9,639

10,168

10,699

10,182

8,113

10,028

9,839

9,891

6,888

7,810

8,746

9,812

6,728

7,638

8,982

8,571

9,610

-

-

-

-

-

-

Prepaid expenses and other current assets

1,622

2,700

3,784

5,503

5,128

1,795

3,274

3,468

2,686

3,276

2,785

2,572

1,636

1,118

-

-

-

793

-

-

-

-

-

-

-

-

Current assets of discontinued operation

-

-

-

-

-

2,066

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,668

1,855

934

-

1,456

1,478

82

601

133

269

287

15

Deferred equity costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

316

316

512

542

-

-

-

-

0

0

0

784

Deferred equity costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

542

589

513

-

-

-

-

-

Total current assets

57,777

60,160

81,508

73,490

94,637

71,141

69,697

79,029

79,328

87,283

67,112

69,807

77,269

84,758

49,008

35,247

36,206

38,676

48,445

42,410

17,267

20,373

24,124

28,102

30,228

851

Property, plant and equipment, net

41,746

42,212

48,067

49,394

46,622

41,700

41,528

38,740

38,486

39,074

38,197

37,638

37,277

37,300

36,487

36,621

36,995

37,922

38,659

39,352

-

-

-

-

-

-

Right-of-use asset

438

485

1,366

1,527

1,693

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred income taxes

-

-

-

-

-

-

25,066

22,696

19,989

18,573

21,759

19,777

18,295

17,060

15,989

16,644

16,043

15,637

-

-

-

-

-

-

-

-

Intangible assets, net

2,637

3,283

30,329

30,974

31,620

5,866

32,912

33,558

34,204

34,850

35,496

36,141

36,787

37,433

38,079

38,725

39,370

40,016

-

-

-

-

-

-

-

-

Intangible assets, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

40,662

41,308

-

-

-

-

-

-

Goodwill

4,319

4,319

6,446

6,446

6,446

4,319

6,446

6,446

6,446

6,446

6,446

6,446

6,446

6,446

6,446

6,446

6,446

6,446

6,744

6,744

-

-

-

-

-

-

Non-current assets of discontinued operation

-

-

-

-

-

32,467

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred financing costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

624

-

-

-

-

-

Total assets

106,917

110,459

167,716

161,831

181,018

155,493

175,649

180,469

178,453

186,226

169,010

169,809

176,074

182,997

146,009

133,683

135,060

138,697

134,510

129,814

17,891

20,373

24,124

28,102

30,228

851

Liabilities and Shareholders’ Equity
Current liabilities:
Convertible notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

11,907

Accounts payable

1,136

989

1,017

706

10,540

2,160

4,888

6,357

4,336

7,954

2,823

3,421

2,954

4,132

1,917

1,752

1,990

1,553

781

767

552

869

682

400

32

434

Accrued expenses and other current liabilities

5,140

4,176

8,556

7,189

10,137

5,597

12,295

9,500

6,361

9,897

9,150

6,551

-

9,893

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of contingent consideration

-

-

-

-

5,235

-

33,957

33,957

33,957

32,053

30,372

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

8,137

-

7,857

5,274

5,606

3,418

4,695

5,888

2,029

575

1,236

937

792

589

Current portion of long-term debt

3,000

-

-

-

-

-

-

-

-

-

0

2,057

1,851

2,236

1,498

5,351

4,859

4,516

13,662

9,123

-

-

-

-

-

-

Current portion of operating lease liability

132

148

525

592

636

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current liabilities of discontinued operation

-

1,172

-

-

-

21,273

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total current liabilities

9,408

6,485

10,098

8,487

26,548

29,030

51,140

49,814

44,654

49,904

42,345

12,029

12,942

16,261

11,272

12,377

12,455

9,487

19,138

15,778

2,582

1,445

1,918

1,337

824

12,930

Long-term debt, net

108,779

110,319

108,859

107,399

105,939

64,243

54,675

54,316

53,957

53,598

24,890

22,657

22,695

22,152

22,738

22,225

22,563

25,244

24,360

36,495

-

-

-

-

-

-

Warrants and other long-term liabilities

-

-

2,040

1,880

838

1,131

801

481

4,290

3,516

3,600

2,788

-

3,397

-

-

-

-

-

-

-

-

-

-

-

-

Long-term portion of operating lease liability and other

924

367

915

1,012

1,136

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-current liabilities of discontinued operation

-

-

-

-

-

80,589

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term portion of contingent consideration

-

-

65,671

61,762

65,585

-

55,486

51,372

50,976

50,360

48,525

-

-

69,574

-

-

-

-

-

-

-

-

-

-

-

-

Warrants

-

-

-

-

-

-

-

-

-

-

-

-

3,688

-

3,817

3,416

2,176

3,770

5,450

6,213

-

-

-

-

-

-

Contingent consideration

-

-

-

-

-

-

-

-

-

-

-

75,347

72,388

-

67,551

64,358

62,824

59,846

57,186

56,600

-

-

-

-

-

-

Total liabilities

119,111

117,171

187,583

180,540

200,046

174,993

162,102

155,983

153,877

157,378

119,360

112,821

111,713

111,384

105,378

102,376

100,018

98,347

106,134

115,086

2,582

1,445

1,918

1,337

824

12,930

Commitments and contingencies (Note 11)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

-

-

-

-

-

-

-

0

Series A redeemable convertible preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

5,880

Shareholders’ equity:
Preferred stock, $0.01 par value. Authorized, 10,000,000 shares; none issued and outstanding

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Common stock, $0.01 par value. Authorized, 50,000,000 shares; issued and outstanding, 23,455,233 shares at March 31, 2020 and 23,312,928 shares at December 31, 2019

234

233

226

224

221

218

207

207

195

191

191

191

190

190

119

99

93

92

92

78

78

77

77

77

77

1

Additional paid-in capital

202,147

199,938

177,281

174,134

170,982

168,535

160,296

157,981

145,367

140,006

136,732

135,083

133,583

132,691

91,378

76,695

72,551

71,321

69,982

54,196

53,463

52,947

52,744

52,588

52,433

-

Accumulated deficit

-214,575

-206,883

-197,374

-193,067

-190,230

-188,253

-146,956

-133,702

-120,985

-111,348

-87,265

-78,210

-69,355

-61,268

-50,866

-45,487

-37,602

-31,063

-41,698

-39,546

-38,231

-34,095

-

-

-

-17,961

Accumulated other comprehensive loss

-

-

-

-

-1

-

-

-

-1

-1

-8

-76

-57

-

-

-

-

-

-

-

-

-

-

-

-

-

Accumulated deficit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

30,614

25,901

23,107

-

Total shareholders’ equity

-12,194

-6,712

-19,867

-18,709

-19,028

-19,500

13,547

24,486

24,576

28,848

49,650

56,988

64,361

71,613

40,631

31,307

35,042

40,350

28,376

14,728

15,309

18,928

22,206

26,764

29,403

-17,959

Total liabilities and shareholders’ equity

106,917

110,459

167,716

161,831

181,018

155,493

175,649

180,469

178,453

186,226

169,010

169,809

176,074

182,997

146,009

133,683

135,060

138,697

134,510

129,814

17,891

20,373

24,124

28,102

30,228

851